Currently the neuraminidase (NA) inhibitor oseltamivir, which can interfere with the enzymatic activity of the NA of the influenza virus, is mainly used for the treatment of influenza patients, but the 2009 H1N1 virus has been reported to be resistant to it [7,8]. The gene discussed is XK; the disease is influenza.